ghk cu dosing guide GHK-Cu Dosing: 1.7mg/Day Injectable (2026) reconstituting ghk cu 100mg dosage

While more large-scale human studies are needed, current research and clinical use suggest that BPC-157 is well tolerated and low-risk when used under medical supervision

These alterations in levels have likely taken years to manifest resulting in well-established functional deficits

Low-quality products may contain impurities, improper copper binding, or degradation products that cause adverse effects while providing minimal benefit

These may include, for example, impaired motor control, behavioral changes such as depression and language problems

FDA raised concerns about impurities, aggregates, endotoxins and immunogenicity